article thumbnail

House of Representatives to Vote on Legislation to Facilitate Clinical Research Studies Using State-Authorized Marijuana Products

NORML

"Legislative action is necessary in this arena because the DEA has proven time and time again that it is not an honest broker in this process.". The post House of Representatives to Vote on Legislation to Facilitate Clinical Research Studies Using State-Authorized Marijuana Products appeared first on NORML.

article thumbnail

Legislation To Produce And Research Cannabis Introduced

NORML

As the result of a lawsuit, DEA Administrative Law Judge Mary Ellen Bittner in 2007 ruled that expanding the pool of federally licensed providers would be “in the public interest.” The agency ultimately rejected her decision.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ASA offers solution to DOJ research block: Our comments on the DEA’s proposed rules

Americans for Safe Access

On March 23, DEA published a proposed rulemaking —“Controls to Enhance the Cultivation of Marihuana for Research in the United States”—in the Federal Register (85 FR 16292), involving who can grow cannabis in bulk for research purposes.

article thumbnail

Congressional Committee to Hold Marijuana Legislative Hearing This Wednesday

NORML

This Wednesday, January 15th, at 10 am EST, the House Energy and Commerce Subcommittee on Health will hold a legislative hearing entitled “Cannabis Policies for the New Decade.” Strait, Senior Policy Advisor, Diversion Control Division, Drug Enforcement Administration (DEA). Witnesses will be: Matthew J. Volkow, M.D.,

article thumbnail

The Tom Marino Roller Coaster: Three Days of Drug Policy Changes

Americans for Safe Access

On October 15, 2017, the Washington Post and 60 Minutes released a scathing report on the pharmaceutical industry’s influence of the Drug Enforcement Administration (DEA).

Policy 182
article thumbnail

NORML “Senate Unanimously Approves Legislation Providing US Attorney General with Greater Say in Cannabis Research Decisions”

Cannabis Law Report

Legislation unanimously passed by members of the US Senate empowers the US Attorney General to facilitate clinical research trials involving cannabis. 253 in the final weeks of the legislative session. Senate Unanimously Approves Legislation Providing US Attorney General with Greater Say in Cannabis Research Decisions.

article thumbnail

From DEA to Legal Cannabis: Charles Feldmann Weighs In

CannaTech

As a Marine Corps federal prosecutor, DEA Drug Task Force Commander and state narcotics prosecutor, Charles spent many years engaged in the War on Drugs. A Former DEA Prosecutor’s Journey into the Global Cannabis Industry. Charles Feldmann, Esq. CannaTech alumnus sponsor and cannabis legal expert. ” – Famous Russian proverb.

DEA 80